Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS
Immunogenicity and Safety Study of Infanrix Hexa in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Pregnant Women
|4||Not yet recruiting||
Heterologous Effect of Diptheria, Tetanus, Acellular Pertussis Vaccination on Influenza Challenge in the Elderly
A Study to Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix® -IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia
Impact of Boostrix™ Maternal Vaccination on Morbidity and Mortality of Pertussis Disease in Infants ≤6 Weeks of Age, in Bogota, Colombia.
Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme
DC Migration Study for Newly-Diagnosed GBM
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery
DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a 2nd Year of Life Booster in HIV-Exposed Infected and Uninfected
Phase 3 Study of BK1310 in Healthy Infants
|13||Not yet recruiting||
A Study of AV0328 Administered to Healthy Adult Volunteers
† Study has passed its completion date and status has not been verified in more than two years.